The search for effective strategies to mitigate inflammation in AD has identified three particularly promising areas of focus: effective degradation of ASC clusters, specific inhibition of NLPR3 (Table 2), and specific Nrf2 activation (Table 3). This evidence concerns the gene NFE2L2 and Alzheimer disease.